ChemScene

Neuromuscular Disorder-Targeting Compound 1 5mg | Technique alternative | 01017489173
CS-7460-5mg Neuromuscular Disord ...
Neuromuscular-targeting compound 1 10mg | Technique alternative | 01017488912
CS-7303-10mg Neuromuscular-target ...
Neuromuscular-targeting compound 1 1mg | Technique alternative | 01017488914
CS-7303-1mg Neuromuscular-target ...
Neuromuscular-targeting compound 1 20mg | Technique alternative | 01017488913
CS-7303-20mg Neuromuscular-target ...
Neuromuscular-targeting compound 1 5mg | Technique alternative | 01017488915
CS-7303-5mg Neuromuscular-target ...
Neuronostatin-13 ( ) 1mg | Technique alternative | 01017487533
CS-0033034-1mg Neuronostatin-13 ( ) ...
Neuronostatin-13 ( ) 5mg | Technique alternative | 01017487534
CS-0033034-5mg Neuronostatin-13 ( ) ...
Neuropeptide W-23( ) 1mg | Technique alternative | 01017487364
CS-7602-1mg Neuropeptide W-23( ) ...
Neuropeptide W-23( ) 5mg | Technique alternative | 01017487365
CS-7602-5mg Neuropeptide W-23( ) ...
Neuropeptide Y (13-36) amide, 1mg | Technique alternative | 01017487610
CS-0044417-1mg Neuropeptide Y (13-3 ...
Neuropeptide Y (13-36) amide, 500ug | Technique alternative | 01017487609
CS-0044417-500ug Neuropeptide Y (13-3 ...
Neuropeptide Y (13-36) amide, 5mg | Technique alternative | 01017487611
CS-0044417-5mg Neuropeptide Y (13-3 ...
Neuropeptide Y (29-64) amide, (TFA) 1mg | Technique alternative | 01017486986
CS-0059278-1mg Neuropeptide Y (29-6 ...
Neuropeptide Y (29-64) amide, (TFA) 5mg | Technique alternative | 01017486987
CS-0059278-5mg Neuropeptide Y (29-6 ...
Neuropeptide Y (29-64) amide, 1mg | Technique alternative | 01017486984
CS-0021292-1mg Neuropeptide Y (29-6 ...
Neuropeptide Y (29-64) amide, 5mg | Technique alternative | 01017486985
CS-0021292-5mg Neuropeptide Y (29-6 ...
Prev  Next